Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|MDA2013-02-02||CLO-MD Anderson||Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication of Barrett’s Esophagus with Radiofrequency Ablation||Cancer Prevention and Control CIRB||Available to Open|
|S1501||SWOG||Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer; Phase III||Cancer Prevention and Control CIRB||Available to Open|
|URCC-16070||NCORP-University of Rochester Cancer Center||Treatment of Refractory Nausea||Cancer Prevention and Control CIRB||Available to Open|
|DCP-001||NCI||Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)||Cancer Prevention and Control CIRB||Available to Open|
|NRG-CC001||NRG||A Randomized Phase III Trial Of Memantine And Whole-Brain Radiotherapy With Or Without Hippocampal Avoidance In Patients With Brain Metastases||Cancer Prevention and Control CIRB||Completed|
|EAQ171CD||ECOG-ACRIN||Implementing a Virtual Tobacco Treatment in Community Oncology Practices: “Smoke Free Support Study 2.0”||Cancer Prevention and Control CIRB||Available to Open|
|WF-97116||NCORP-Wake Forest University||A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors with Cognitive Impairment||Cancer Prevention and Control CIRB||Available to Open|
|WF-1802||NCORP-Wake Forest University||Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW)||Cancer Prevention and Control CIRB||Available to Open|
|UAZ2015-05-01||CLO-University of Arizona||A prospective, single-arm, open-label, non-randomized, phase IIA trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys||Cancer Prevention and Control CIRB||Available to Open|
|A221505||Alliance||Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction||Cancer Prevention and Control CIRB||Available to Open|